An integrated approach for the in vitro dosimetry of engineered nanomaterials

Particle and Fibre Toxicology

Volumn 11, Issue 1, 2014, Pages

  Cohen, Joel M ^a   Teeguarden, Justin G ^b   Demokritou, Philip ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONACEOUS NANOPARTICLE; ENGINEERED NANOMATERIAL; GOLD NANOSPHERE; METAL; METAL OXIDE; NANOMATERIAL; UNCLASSIFIED DRUG;

AGGLOMERATE DIAMETER; ARTICLE; CELL CULTURE; DENSITY; DOSIMETRY; EXPOSURE; HYDRODYNAMICS; IN VITRO STUDY; MEASUREMENT ACCURACY; MOLECULAR WEIGHT; NANOENGINEERING; NANOTOXICOLOGY; NEUTRON DOSIMETER; PARTICLE NUMBER; PHYSICAL PARAMETERS; PRIORITY JOURNAL; STANDARDIZATION; SURFACE AREA; SURFACE PROPERTY; VALIDATION PROCESS;

ALGORITHMS; ANIMALS; CENTRIFUGATION; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; METAL NANOPARTICLES; METALS; NANOSTRUCTURES; NEUTRON ACTIVATION ANALYSIS; OXIDES; PARTICLE SIZE; SUSPENSIONS; TOXICITY TESTS;

EID: 84901620667     PISSN: None     EISSN: 17438977     Source Type: Journal    
DOI: 10.1186/1743-8977-11-20     Document Type: Article

References (53)

1. Bello D, Martin J, Santeufemio C, Sun Q, Lee Bunker K, Shafer M, Demokritou P. Physicochemical and morphological characterisation of nanoparticles from photocopiers: implications for environmental health. Nanotoxicology 2013, 7(5):989-1003. 10.3109/17435390.2012.689883, 22551088.
2. Pirela S, Molina R, Watson C, Cohen JM, Bello D, Demokritou P, Brain J. Effects of copy center particles on the lungs: a toxicological characterization using a Balb/c mouse model. Inhal Toxicol 2013, 25(9):498-508. 10.3109/08958378.2013.806614, 23895351.
3. Choi HS, Ashitate Y, Lee JH, Kim SH, Matsui A, Insin N, Bawendi MG, Semmler-Behnke M, Frangioni JV, Tsuda A. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotechnol 2010, 28(12):1300-1303. 10.1038/nbt.1696, 3058321, 21057497.
4. Brain J. Biologic responses to nanomaterials depend on exposure, clearance, and material characteristics. Nanotoxicology 2009, 3(3):174-180.
5. Mills NL, Donaldson K, Hadoke PW, Boon NA, MacNee W, Cassee FR, Sandstrom T, Blomberg A, Newby DE. Adverse cardiovascular effects of air pollution. Nat Clin Pract Cardiovasc Med 2009, 6(1):36-44. 10.1038/ncpcardio1399, 19029991.
6. Demokritou P, Gass S, Pyrgiotakis G, Cohen JM, Goldsmith W, McKinney W, Frazer D, Ma J, Schwegler-Berry D, Brain J, Castranova V. An in vivo and in vitro toxicological characterization of realistic nanoscale CeO2 inhalation exposures. Nanotoxicology 2013, 7(8):1338-1350. 10.3109/17435390.2012.739665, 23061914.
7. Sotiriou GA, Diaz E, Long MS, Godleski J, Brain J, Pratsinis SE, Demokritou P. A novel platform for pulmonary and cardiovascular toxicological characterization of inhaled engineered nanomaterials. Nanotoxicology 2012, 6(6):680-690. 10.3109/17435390.2011.604439, 3641536, 21809902.
8. Oberdorster G. Toxicology of nanoparticles: A histroical perspective. Nanotoxicology 2007, 1(1):1-25.
9. Nel AE, Madler L, Velegol D, Xia T, Hoek EM, Somasundaran P, Klaessig F, Castranova V, Thompson M. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 2009, 8(7):543-557. 10.1038/nmat2442, 19525947.
10. Lai DY. Toward toxicity testing of nanomaterials in the 21st century: a paradigm for moving forward. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011, 4(1):1-15.
11. Balbus JM, Maynard AD, Colvin VL, Castranova V, Daston GP, Denison RA, Dreher KL, Goering PL, Goldberg AM, Kulinowski KM, Monteiro-Riveiere NA, Oberdorster G, Omenn GS, Pinkerton KE, Ramos KS, Rest KM, Sass JB, Silbergeld EK, Wong BA. Meeting report: hazard assessment for nanoparticles-report from an interdisciplinary workshop. Environ Health Perspect 2007, 115(11):1654-1659. 10.1289/ehp.10327, 2072837, 18007999.
12. Nel A, Xia T, Madler I, Li N. Toxic potential of materials at the nanolevel. Science 2006, 311(5761):622-627. 10.1126/science.1114397, 16456071.
13. Krewski D, Acosta D, Andersen M, Anderson H, Bailar JC, Boekelheide K, Brent R, Charnley G, Cheung VG, Green S, Kelsey KT, Kerkvliet NI, Li AA, McCray L, Meyer O, Patterson RD, Pennie W, Scala RA, Solomon GM, Stephens M, Yager J, Zeise L. Toxicity testing in the 21st century: a vision and a strategy. J Toxicol Environ Health B Crit Rev 2010, 13(2-4):51-138.
14. Nanoscale Science, E.a.T.S.C.o.T.N.S.a.T.C National Nanotechnology Initiative Strategic Plan 2011, Washington D.C: N.S.a.T. Council, Editor, Nanoscale Science, E.a.T.S.C.o.T.N.S.a.T.C.
15. Gangwal S, Brown JS, Wang A, Houck KA, Dix DJ, Kavlock RJ, Hubal EA. Informing selection of nanomaterial concentrations for ToxCast in vitro testing based on occupational exposure potential. Environ Health Perspect 2011, 119(11):1539-1546. 10.1289/ehp.1103750, 3226507, 21788197.
16. Oberdorster G. Nanotoxicology: in vitro-in vivo dosimetry. Environ Health Perspect 2012, 120(1):A13. author reply A13, 3261953, 22214547.
17. Han X, Corson N, Wade-Mercer P, Gelein R, Jiang J, Sahu M, Biswas P, Finkelstein JN, Elder A, Oberdorster G. Assessing the relevance of in vitro studies in nanotoxicology by examining correlations between in vitro and in vivo data. Toxicology 2012, 297(1-3):1-9. 3350601, 22487507.
18. Rivera Gil P, Oberdorster G, Elder A, Puntes V, Parak WJ. Correlating physico-chemical with toxicological properties of nanoparticles: the present and the future. ACS Nano 2010, 4(10):5527-5531. 10.1021/nn1025687, 20973573.
19. Warheit DB, Sayes CM, Reed KL. Nanoscale and fine zinc oxide particles: can in vitro assays accurately forecast lung hazards following inhalation exposures?. Environ Sci Technol 2009, 43(20):7939-7945. 10.1021/es901453p, 19921917.
20. Donaldson K, Schinwald A, Murphy F, Cho WS, Duffin R, Tran L, Poland C. The Biologically effective dose in inhalation nanotoxicology. Acc Chem Res 2013, 46(3):723-732. 10.1021/ar300092y, 23003923.
21. Rushton EK, Jiang J, Leonard SS, Eberly S, Castranova V, Biswas P, Elder A, Han X, Gelein R, Finkelstein J, Oberdorster G. Concept of assessing nanoparticle hazards considering nanoparticle dosemetric and chemical/biological response metrics. J Toxicol Environ Health A 2010, 73(5):445-461. 3884809, 20155585.
22. Cho WS, Duffin R, Thielbeer F, Bradley M, Megson IL, Macnee W, Poland CA, Tran CL, Donaldson K. Zeta potential and solubility to toxic ions as mechanisms of lung inflammation caused by metal/metal oxide nanoparticles. Toxicol Sci 2012, 126(2):469-477. 10.1093/toxsci/kfs006, 22240982.
23. Cohen J, Deloid G, Pyrgiotakis G, Demokritou P. Interactions of engineered nanomaterials in physiological media and implications for in vitro dosimetry. Nanotoxicology 2013, 7(4):417-431. 10.3109/17435390.2012.666576, 22393878.
24. Deloid G, Cohen J, Darrah T, Derk R, Rojanasakul L, Pyrgiotakis G, Wohlleben W, Demokritou P. Estimating effective density of engineered nanomaterials for in vitro dosimetry. Nat Commun 2014, doi:10.138/ncomms4514.
25. Schulze C, Kroll A, Lehr CM, Schafer U, Becker K, Schnekenburger J, Schulze-Isfort C, Landsiedel R, Wohllebene W. Not ready to use - overcoming pitfalls when dispersing nanoparticles in physiological media. Nanotoxicology 2008, 2(2):51-61.
26. Verma A, Stellacci F. Effect of surface properties on nanoparticle-cell interactions. Small 2010, 6(1):12-21. 10.1002/smll.200901158, 19844908.
27. Demokritou P, Cohen J, DeLoid G. Novel Methods of Measuring Effective Density of Nanoparticles in Fluids 2012, U.S. Patent Application 61/661,895.
28. Sterling MC, Bonner JS, Ernest AN, Page CA, Autenrieth RL. Application of fractal flocculation and vertical transport model to aquatic sol-sediment systems. Water Res 2005, 39(9):1818-1830. 10.1016/j.watres.2005.02.007, 15899280.
29. Hinderliter PM, Minard KR, Orr G, Chrisler WB, Thrall BD, Pounds JG, Teeguarden JG. ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies. Part Fibre Toxicol 2010, 7(1):36. 10.1186/1743-8977-7-36, 3012653, 21118529.
30. Limbach L, Li Y, Grass RN, Brunner TJ, Hintermann MA, Muller M, Gunther D, Stark WJ. Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations. Environ Sci Technol 2005, 39:7.
31. Teeguarden JG, Hinderliter PM, Orr G, Thrall BD, Pounds JG. Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol Sci 2007, 95(2):300-312.
32. Lison D, Thomassen LC, Rabolli V, Gonazalez L, Napierska D, Seo JW, Kirsch-Volders M, Hoet P, Kirschlock CE, Martens JA. Nominal and effective dosimetry of silica nanoparticles in cytotoxicity assays. Toxicol Sci 2008, 104(1):155-162. 10.1093/toxsci/kfn072, 18400775.
33. Cho EC, Zhang Q, Xia Y. The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles. Nat Nanotechnol 2011, 6(6):385-391. 10.1038/nnano.2011.58, 3227810, 21516092.
34. Ahmad Khanbeigi R, Kumar A, Sadouki F, Lorenz C, Forbes B, Dailey LA, Collins H. The delivered dose: Applying particokinetics to in vitro investigations of nanoparticle internalization by macrophages. J Control Release 2012, 162(2):259-266. 10.1016/j.jconrel.2012.07.019, 22824784.
35. Sharma G, Kodali V, Gaffrey M, Wang W, Minard KR, Karin NJ, Teeguarden JG, Thrall BD. Iron oxide nanoparticle agglomeration influences dose rates and modulates oxidative stress-mediated dose-response profiles in vitro. Nanotoxicology 2014, 8:663-675. 10.3109/17435390.2013.822115, 23837572.
36. George S, Xia T, Rallo R, Zhao Y, Ji Z, Lin S, Wang X, Zhang H, France B, Schoenfeld D, Damoiseaux R, Liu R, Lin S, Bradley KA, Cohen Y, Nel AE. Use of a high-throughput screening approach coupled with in vivo Zebrafish embryo screening to develop hazard ranking for engineered Nanomaterials. ACS Nano 2011, 5(3):1805-1817. 10.1021/nn102734s, 3896549, 21323332.
37. Zhang H, Ji Z, Xia T, Meng H, Low-Kam C, Liu R, Pokhrel S, Lin S, Wang X, Liao YP, Wang M, Li L, Rallo R, Damoiseaux R, Telesca D, Madler L, Cohen Y, Zink JI, Nel AE. Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation. ACS Nano 2012, 6(5):4349-4368. 10.1021/nn3010087, 22502734.
38. Demokritou P, Buchel R, Molina RM, Deloid GM, Brain JD, Pratsinis SE. Development and characterization of a Versatile Engineered Nanomaterial Generation System (VENGES) suitable for toxicological studies. Inhal Toxicol 2010, 22(Suppl 2):107-116.
39. Gass S, Cohen JM, Pyrgiotakis G, Sotiriou GA, Pratsinis SE, Demokritou P. A safer formulation concept for flame-generated engineered nanomaterials. ACS Sustain Chem Eng 2013, 1(7):843-857.
40. Wegner K, Pratsinis SE. Scale-up of nanoparticle synthesis in diffusion flame reactors. Chem Eng Sci 2003, 58(20):9.
41. Wittmaack K. Novel dose metric for apparent cytotoxicity effects generated by in vitro cell exposure to silica nanoparticles. Chem Res Toxicol 2011, 24(2):150-158. 10.1021/tx100331w, 21171596.
42. Cohen JM, Derk R, Rojanasakul L, Godleski JJ, Kobzik L, Brain JD, Demokritou P. Tracking translocation of industrially relevant engineered nanomaterials across alveolar epithelial monolayers in vitro. Nanotoxicology 2014, doi:10.3109/17435390.2013.879612.
43. He X, Zhang H, Ma Y, Bai W, Zhang Z, Lu K, Ding Y, Zhao Y, Chai Z. Lung deposition and extrapulmonary translocation of nano-ceria after intratracheal instillation. Nanotechnology 2010, 21(28):285103. 10.1088/0957-4484/21/28/285103, 20562477.
44. Monopoli MP, Walcyk D, Campbell A, Elia G, Lynch I, Bombelli FB, Dawson KA. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 2011, 133(8):2525-2534. 10.1021/ja107583h, 21288025.
45. Monopoli MP, Aberg C, Salvati A, Dawson KA. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol 2012, 7(12):779-786. 10.1038/nnano.2012.207, 23212421.
46. Salvati A, Pitek AS, Monopoli MP, Prapainop K, Bombelli FB, Hristov DR, Kelly PM, Aberg C, Mahon E, Dawson KA. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol 2013, 8(2):137-143. 10.1038/nnano.2012.237, 23334168.
47. Pyrgiotakis GP, Blattman CO, Patsinis S, Demokritou P. Nanoparticle-nanoparticle interactions in biological media by atomic force microscopy. Langmuir 2013, 29(36):11385-11395. 10.1021/la4019585, 23978039.
48. Khatri M, Bello D, Pal AP, Cohen JM, Woskie S, Gassert T, Lan J, Gu AZ, Demokritou P, Gaines P. Evaluation of cytotoxic, genotoxic and inflammatory responses of nanoparticles from photocopiers in three human cell lines. Part Fibre Toxicol 2013, 10(42). doi:10.1186/1743-8977-10-42.
49. Bello DH, Hsieh SF, Schmidt D, Rogers E. Nanomaterials properties vs. biological oxidative damage: Implications for toxicity screening and exposure assessment. Nanotoxicology 2009, 3(3):249-262.
50. Elder A, Gelein R, Finkelstein JC, Driscoll KE, Harkema J, Oberdorster G. Effects of subchronically inhaled carbon black in three species. I. Retention kinetics, lung inflammation, and histopathology. Toxicol Sci 2005, 88(2):614-629. 10.1093/toxsci/kfi327, 16177241.
51. Zhu T, Vasilev K, Kreiter M, Mittler S, Knolls W. Surface modification of citrate-reduced colloidal gold nanoparticles with 2-Mercaptosuccinic Acid. Langmuir 2003, 19:9518-9525.
52. Haynes WM. CRC Handbook of Chemistry and Physics 2012, Boca Raton, FL, USA: CRC Press/Taylor and Francis, 92.
53. Song C, Wang P, Makse HA. A phase diagram for jammed matter. Nature 2008, 453(7195):629-632. 10.1038/nature06981, 18509438.